Altogether, these data redefine the current CXCR4/CD5 kinetics model, demonstrating that the PF is enriched for G1 cells while mitotic CLL cells express high levels of both CXCR4 and CD5. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.